相关实验视频

Updated: Jun 12, 2025

Establishment and Characterization of Three Afatinib-resistant Lung Adenocarcinoma PC-9 Cell Lines Developed with Increasing Doses of Afatinib

Establishment and Characterization of Three Afatinib-resistant Lung Adenocarcinoma PC-9 Cell Lines Developed with Increasing Doses of Afatinib

Published on: June 26, 2019

[EGFR Exon 20插入突变:研究现状和新的治疗策略]

Mengwei Tian¹, Na Wang¹, Zhanjun Dou²

¹The Second Clinical Medical College of Shanxi Medical University, Taiyuan 030001, China.

Zhongguo fei ai za zhi = Chinese journal of lung cancer

|September 25, 2024

概括

在非小细胞肺癌 (NSCLC) 中,表皮生长因子受体外20插入 (EGFR ex20ins) 突变对当前疗法具有抗性. 本综述总结了新的向药物和组合疗法,为EGFR ex20ins NSCLC患者提供了希望.

科学领域:

在瘤学瘤学.
分子生物学分子生物学
药理学药理学是一个学科.

背景情况:

皮表皮生长因子受体外20插入 (EGFR ex20ins) 是非小细胞肺癌 (NSCLC) 的关键驱动因素.
EGFR ex20ins突变赋予了对传统的EGFR-氨酸激酶抑制剂 (EGFR-TKI) 的耐药性.
新的向疗法正在出现,以解决这个尚未满足的需求.

研究的目的:

审查针对EGFR ex20ins突变NSCLC的向疗法的最新进展.
评估新批准和试验药物之间的疗效和差异.
为EGFR ex20ins NSCLC提供精密治疗的参考.

主要方法:

最近的临床试验和研究出版物的文献综述.
药物批准和治疗突破的分析.
对新药和组合策略的比较评估.

主要成果:

莫博塞蒂尼布和阿米万塔马布已获得FDA的批准,用于EGFR ex20ins NSCLC.
像Sunvozertinib这样的其他药物显示出有前途.
组合疗法也在证明其有效性.

结论:

新兴的向疗法为克服EGFR ex20ins NSCLC药物耐药性的新希望.
了解分子机制和药物差异对于有效的治疗选择至关重要.
多方位治疗方法对于改善EGFR ex20ins的NSCLC患者的治疗结果至关重要.

关键词:

皮肤表皮生长因子受体.埃克松20插入突变突变肺部瘤是什么意思有针对性的治疗.

更多相关视频

Author Spotlight: Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer

Author Spotlight: Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer

Published on: September 8, 2023

Establishing Dual Resistance to EGFR-TKI and MET-TKI in Lung Adenocarcinoma Cells In Vitro with a 2-step Dose-escalation Procedure

Establishing Dual Resistance to EGFR-TKI and MET-TKI in Lung Adenocarcinoma Cells In Vitro with a 2-step Dose-escalation Procedure

Published on: August 11, 2017

相关概念视频

Mitogens and the Cell Cycle

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

Gene Therapy

Gene Therapy

Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...